'Weight-loss (ozempic) is a big opportunity in the pharma space. See some value in the complex generics space. Sun Pharma has the cash and platform to build out innovation. Oncology is the fast-growing segment with a lot of opportunity. Have a Buy on Jubilant Pharmova, Krsnaa Diagnostics and SastaSundar Ventures.', says Vishal Manchanda, Sr. VP, Institutional Research, Systematix Group
#systematixgroup #etnow #businessnews #nifty #sharenews #topnews
Subscribe To ET Now For Latest Updates On Stocks, Business, Trading | ► [ Ссылка ]
Subscribe Now To Our Network Channels :-
Times Now : [ Ссылка ]
The NewsHour Debate : [ Ссылка ]
To Stay Updated Download the Times Now App :-
Android Google Play : [ Ссылка ]
Apple App Store : [ Ссылка ]
Social Media Links :-
Twitter - [ Ссылка ]
Facebook - [ Ссылка ]
G+ - [ Ссылка ]
Website - www.etnownews.com
